Cyclophosphamide. In DorrR. T.FritzW. L., Cancer Chemotherapy Handbook.New York: Elsevier, 1980, p. 342–351.
2.
ColvinH.HiltonJ.Pharmacology of cyclophosphamide and metabolitesCancer Treat. Rep.65:Suppl 3:89–95, 1981.
3.
Cyclophosphamide. In American Hospital Formulary Service: Drug Information.Washington, D. C: American Society of Hospital Pharmacists. 1984, p. 238–242.
4.
GrochowL. B.ColvinM.Clinical pharmacokinetics of cyclophosphamideClin. Pharmacokinet.4:380–394, 1979.
5.
FettingJ. H.The course of nausea and vomiting after high-dose cyclophosphamideCancer Treat. Rep.66:1487–1493, 1982.
6.
KleinF.A.SmithM. J. V.Urinary complications of cyclophosphamide therapy: Etiology, prevention and managementSouth. Med. J.76:1413–1416, 1983.
7.
LawrenceH.J.SimoneJ.AurR.J.Cyclophosphamide-induced hemorrhagic cystitis in children with leukemiaCancer36:1572–1576, 1975.
8.
BischelM.Cyclophosphamide — hemorrhagic cystitis following prolonged low-dose therapyJAMA242:238–239, 1979.
9.
SpiersA. S.ChikkappaG.WilburH. J.Hemorrhagic cystitis after low-dose cyclophosphamideLancet1:1213–1214, 1983.
10.
PyeritzR.D.An approach to the control of massive hemorrhage in cyclophosphamide — induced cystitis by intravenous vasopressin: A case reportJ. Urol.120:253–254, 1978.
11.
CoxP.J.Cyclophosphamide cystitis— identification of acrolein as the causative agentBiochem. Pharmacol.28:2045–2049, 1979.
12.
PriraackA.Amelioration of cyclophosphamide — induced cystitisJ. Natl. Cancer Inst.47:223–227, 1971.
13.
BottaJ.A.NelsonL.W.WeikelJ.Acetylcysteine in the prevention of cyclophosphamide — induced cystitis in ratsJ. Natl. Cancer Inst.51:1051–1058, 1973.
14.
TolleyD.A.The effect of N-acetylcysteine on cyclophosphamide cystitisBrit. J. Urol.49:659–661, 1977.
15.
BerriganM.J.Protective role of thiols in cyclophosphamide — induced uro-toxicity and depression of hepatic drug metabolismCancer Res.42:3688–3695, 1982.
16.
MorganL.R.The control of ifos***-famide — induced hematuria with N-acetylcysteine in patients with advanced carcinoma of the lungSemin. Oncol.9(4 Suppl 1):71–74, 1982.
17.
HoloyeP.Y.Prophylaxis of ifosfamide toxicity with oral acetylcysteineSemin. Oncol.10(1 Suppl 1):66–71, 1983.
18.
SlavikM.SaiersJ.Phase I clinical study of acetylcysteine's preventing ifosfamide-induced hematuriaSemin. Oncol.10(1 Suppl 1):62–65, 1983.
19.
LoehrerP. J.WilliamsS.D.EinhornL.N-acetylcysteine and ifosfamide in the treatment of unresectable pancreatic adenocarcinoma and refractory testicular cancerSemin. Oncol.10(1 Suppl 1): 72–75, 1983.
20.
MorganL.HoldinessM.GillenL.N-acetylcysteine: Its bioavailability and interaction with ifosfamide metabolitesSemin. Oncol.10(1 Suppl 1):56–61, 1983.
21.
ShromS. N.Formalin treatment for intractable hemorrhagic cystitis: A review of the literature with 16 additional casesCancer38:1785–1789, 1976.
22.
DeFronzoR.A.Water intoxication in man after cyclophosphamide therapy: Time course and relation to drug activationAnn. Intern. Med.78:861–869, 1973.
23.
HarlowP.J.A fatal case of inappropriate ADH secretion induced by cyclophosphamide therapyCancer44:896–898, 1979.
24.
MillsB.A.RobertsR.W.Cyclophosphamide-induced cardiomyopathy: A report of two cases and review of the English literatureCancer43:2223–2226, 1979.
25.
GottdienerJ. S.Cardiotoxicity associated with high — dose cyclophosphamide therapyArch. Intern. Med.141:758–763, 1981.
26.
PatelA.Cyclophosphamide therapy and interstitial pulmonary fibrosisCancer38:1542–1549, 1976.
